Tag: Antisense Therapeutics
Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study
Antisense Therapeutics Starts dosing monkeys in ATL1102 toxicology studyAntisense Therapeutics (ANP) commences the dosing stage of a nine-month...
Antisense Therapeutics: Receives first approval for phase two DMD clinical trial
Antisense Therapeutics Receives first approval for phase two DMD clinical trialAntisense Therapeutics (ANP) receives approval to conduct its...
Antisense Therapeutics: Shares rise on long COVID-19 study
Antisense Therapeutics Shares rise on long COVID-19 studyAntisense Therapeutics (ANP) announces the outcomes of its collaboration to study...
Antisense Therapeutics: Raises $5.5M for Phase 2b clinical trial
Antisense Therapeutics: Raises $5.5M for Phase 2b clinical trialBiopharmaceutical company Antisense Therapeutics (ANP) has raised $5.5 million via...